Nuvectra Submits Chemical Composition and Biocompatibility Data to FDA for Virtis™
18 oct. 2019 08h00 HE
|
Nuvectra Corporation
PLANO, Texas, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced it has submitted supplementary chemical composition...
Nuvectra® Appoints Jennifer Kosharek as Chief Financial Officer
20 sept. 2019 08h30 HE
|
Nuvectra Corporation
PLANO, Texas, Sept. 20, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Jennifer Kosharek as Chief...
Nuvectra® Exploring Strategic Options to Enhance Shareholder Value
26 août 2019 16h05 HE
|
Nuvectra Corporation
PLANO, Texas, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced that its Board of Directors has decided to explore...
Nuvectra® Reports Second Quarter 2019 Financial Results
31 juil. 2019 16h01 HE
|
Nuvectra Corporation
PLANO, Texas, July 31, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended June...
Nuvectra to Report Second Quarter 2019 Financial Results on July 31, 2019
17 juil. 2019 08h30 HE
|
Nuvectra Corporation
PLANO, Texas, July 17, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the...
Nuvectra® to Participate in Two Upcoming Investor Conferences
12 juin 2019 16h05 HE
|
Nuvectra Corporation
PLANO, Texas, June 12, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that members of management are scheduled to...
Nuvectra Files Regulatory Submission with FDA for Algovita® Full-Body MR-Conditional Approval
11 juin 2019 16h05 HE
|
Nuvectra Corporation
PLANO, Texas, June 11, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has filed its regulatory submission with the...
Nuvectra Highlights Positive Preliminary Algovita® Clinical Data at the INS 14th Annual World Congress
30 mai 2019 08h30 HE
|
Nuvectra Corporation
PLANO, Texas,, May 30, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today preliminary Algovita® clinical data from its U.S. and...
Nuvectra® Announces Departure of COO & CFO Walter Z. Berger
16 mai 2019 09h00 HE
|
Nuvectra Corporation
PLANO, Texas, May 16, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced that Walter Z. Berger has resigned as Nuvectra’s Chief...
Nuvectra® Reports First Quarter 2019 Financial Results
01 mai 2019 16h01 HE
|
Nuvectra Corporation
PLANO, Texas, May 01, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended March 31,...